DekaBank Deutsche Girozentrale’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.04M | Hold |
49,500
| – | – | ﹤0.01% | 739 |
|
2025
Q1 | $1.88M | Hold |
49,500
| – | – | ﹤0.01% | 745 |
|
2024
Q4 | $1.78M | Hold |
49,500
| – | – | ﹤0.01% | 772 |
|
2024
Q3 | $1.88M | Hold |
49,500
| – | – | ﹤0.01% | 771 |
|
2024
Q2 | $1.88M | Hold |
49,500
| – | – | ﹤0.01% | 774 |
|
2024
Q1 | $1.88M | Hold |
49,500
| – | – | ﹤0.01% | 771 |
|
2023
Q4 | $579K | Hold |
49,500
| – | – | ﹤0.01% | 1008 |
|
2023
Q3 | $484K | Hold |
49,500
| – | – | ﹤0.01% | 1021 |
|
2023
Q2 | $571K | Hold |
49,500
| – | – | ﹤0.01% | 1002 |
|
2023
Q1 | $574K | Hold |
49,500
| – | – | ﹤0.01% | 989 |
|
2022
Q4 | $668K | Hold |
49,500
| – | – | ﹤0.01% | 972 |
|
2022
Q3 | $669K | Hold |
49,500
| – | – | ﹤0.01% | 985 |
|
2022
Q2 | $566K | Buy |
+49,500
| New | +$566K | ﹤0.01% | 1000 |
|
2022
Q1 | – | Sell |
-45,000
| Closed | -$892K | – | 1391 |
|
2021
Q4 | $892K | Buy |
+45,000
| New | +$892K | ﹤0.01% | 959 |
|